| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $109.2M | -19.6% |
| Cost of Revenue | $75.6M | -15.0% |
| Gross Profit | $33.6M | -28.4% |
| R&D Expense | $4.3M | +3.5% |
| SG&A Expense | $35.5M | -43.1% |
| Operating Income | -$16.4M | +15.9% |
| Pre-tax Income | -$24.7M | +18.2% |
| Income Tax | -$920K | +51.8% |
| Net Income | -$23.8M | +16.0% |
| EPS (Basic) | -$39.74 | -163.0% |
| EPS (Diluted) | -$39.74 | -163.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.4M | +17.0% |
| Accounts Receivable | $15.4M | -16.2% |
| Inventory | $38.1M | -11.9% |
| Current Assets | $69.5M | -11.4% |
| Total Assets | $97.5M | -15.4% |
| Current Liabilities | $42.9M | -44.4% |
| Long-term Debt | $34.2M | -8.1% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.3M | -659.7% |
| Capital Expenditures | $102K | -79.8% |
| Investing Cash Flow | -$102K | +79.8% |
| Financing Cash Flow | $3.4M | +147.5% |
| Free Cash Flow | -$3.4M | -263.7% |
| $96.3M |
| -3.4% |
| Stockholders' Equity | $1.3M | +109.7% |